Genetically engineered mouse models of Parkinson's disease.

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Parkinson's disease (PD) is a prevalent neurodegenerative disorder affecting over 1% of individuals over 60.
• Key features include resting tremor and systemic effects like incontinence and sleep disturbances.
• Histopathological hallmarks are Lewy bodies, primarily composed of alpha-synuclein.

Purpose of the Study:

• To review commonly used genetic mouse models for Parkinson's disease research.
• To explore how these models advance understanding of PD pathogenesis and progression.
• To identify potential therapeutic targets for Parkinson's disease.

Main Methods:

• Focus on alpha-synuclein transgenic mouse models (wildtype and mutant).
• Examination of gene-disrupted or -mutated models based on human genetic anomalies.
• Inclusion of models investigating genes in nigrostriatal pathway signaling.

Main Results:

• Alpha-synuclein models are the most utilized due to its direct role in PD.
• Various genetic models illuminate different facets of PD pathogenesis.
• These models facilitate the identification of novel therapeutic strategies.

Conclusions:

• Genetic mouse models are indispensable tools for Parkinson's disease research.
• Continued development and utilization of these models are vital for advancing therapeutic interventions.
• Understanding genetic contributions is key to combating PD progression.